E Med Future, Inc. (EMDF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerE Med Future, Inc. (EMDF) trades at $0.0033. E Med Future, Inc. specializes in manufacturing safety devices aimed at reducing accidental hypodermic needlestick injuries. Sector: Healthcare.
Price as of Sep 10, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for EMDF: EMDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EMDF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
EMDF: 1/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
E Med Future, Inc. (EMDF) Healthcare & Pipeline Overview
E Med Future, Inc. is a niche player in the healthcare sector, focusing on innovative safety devices that mitigate the risks associated with hypodermic needlestick injuries, catering to various professional sectors including healthcare and law enforcement.
What Is the Investment Thesis for EMDF?
E Med Future, Inc. operates in a specialized segment of the healthcare market with a focus on safety devices aimed at reducing needlestick injuries, a significant concern in medical environments. The company's innovative products, particularly NeedleZap, have the potential to capture a growing market as awareness of safety in healthcare increases. With a gross margin of 65.8%, E Med Future demonstrates strong profitability potential, although it currently faces challenges reflected in a profit margin of -182.1%. The ongoing expansion of healthcare services and an increasing emphasis on safety protocols present growth catalysts for the company. Additionally, the diversification of its product offerings to include devices for various sectors enhances its market appeal. However, the company must navigate risks associated with limited resources, given its small employee base of two, which may impact its ability to scale operations effectively. The need for strategic partnerships and potential funding will be crucial for sustaining growth and addressing market needs.
Based on FMP financials and quantitative analysis
EMDF Key Highlights
Market Cap: $0.00B indicates the company's current valuation in the OTC market.
- Profit Margin: -182.1% reflects significant challenges in achieving profitability.
- Gross Margin: 65.8% demonstrates strong potential for profitability if operational efficiencies are achieved.
- Beta: -0.83 suggests lower volatility compared to the broader market, indicating stability in uncertain conditions.
- Employee Count: 2 highlights the company's small operational scale, which may impact growth capabilities.
Who Are EMDF's Competitors?
EMDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BDX Becton, Dickinson and Company | $176.42 | -1.88% | $48.6B | 705-pillar |
| HOLX Hologic, Inc. | $76.01 | +0.00% | $17.0B | — |
| SYK Stryker Corporation | $275.80 | +0.15% | $106B | 775-pillar |
| RDGL Vivos Inc. | $0.05 | 0.00% | $23.9M | 619-signal |
| SNWV SANUWAVE Health, Inc. | $4.00 | -0.99% | $34.4M | 365-pillar |
| HYPD Hyperion DeFi, Inc. | $3.59 | -2.18% | $54.4M | 365-pillar |
| LNSR LENSAR, Inc. | $8.23 | -0.96% | $101M | 485-pillar |
| APYX Apyx Medical Corporation | $2.89 | -5.25% | $122M | 365-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are EMDF's Key Strengths?
Innovative product offerings focused on safety.
- Strong gross margin indicating potential profitability.
- Niche market focus reduces direct competition.
What Are EMDF's Weaknesses?
Small employee base limits operational capacity.
- Negative profit margin reflects current financial challenges.
- Limited brand recognition compared to larger competitors.
What Could Drive EMDF Stock Higher?
Potential partnerships with healthcare institutions to enhance product adoption.
- Development of new safety devices to expand product offerings.
- Marketing campaigns aimed at raising awareness about needlestick injuries.
What Are the Key Risks for EMDF?
Financial-distress signal — its Altman Z-Score of 0.06 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-9.6%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Increased competition from larger medical device manufacturers.
- Financial challenges reflected in negative profit margins.
- Regulatory changes that could impact product development timelines.
What Are the Growth Opportunities for EMDF?
- Expansion into New Markets: E Med Future can explore international markets where healthcare safety regulations are becoming stricter. The global market for safety medical devices is expected to grow significantly, with estimates suggesting a CAGR of 6.5% through 2027. By targeting regions with increasing healthcare investments, the company can enhance its market presence and drive revenue growth.
- Partnerships with Healthcare Institutions: Collaborating with hospitals and healthcare organizations can facilitate the adoption of E Med Future's products. As healthcare providers increasingly prioritize safety, strategic partnerships can lead to bulk purchasing agreements, thereby boosting sales and market penetration. This approach can also enhance brand visibility and credibility.
- Product Line Diversification: Introducing additional safety devices tailored to specific healthcare applications can attract a broader customer base. By expanding its product offerings, E Med Future can address various needs within the healthcare sector, including specialized devices for emergency services and veterinary applications, potentially increasing its market share.
- Regulatory Compliance and Certification: Achieving certifications from regulatory bodies can enhance product credibility and open up new sales channels. As healthcare facilities strive to meet compliance standards, having certified safety devices can position E Med Future favorably in competitive bidding processes.
- Increased Awareness Campaigns: Investing in marketing and educational campaigns to raise awareness about the dangers of needlestick injuries can drive demand for E Med Future's products. By positioning itself as a thought leader in safety, the company can attract attention from healthcare professionals and organizations focused on improving safety protocols.
What Threats Does EMDF Face?
- Intense competition from established medical device manufacturers.
- Regulatory changes that could impact product development.
- Market volatility affecting funding and operational stability.
What Are EMDF's Competitive Advantages?
- Specialization in safety devices creates a niche market position.
- Innovative product design enhances competitive differentiation.
- Focus on regulatory compliance can build trust with healthcare providers.
What Does EMDF Do?
E Med Future, Inc., founded in 1990 and headquartered in Sarasota, US, is dedicated to enhancing safety in medical and related fields through innovative products designed to minimize the risk of accidental hypodermic needlestick injuries. The company’s flagship product, NeedleZap, is engineered to safely disintegrate the sharp portion of a hypodermic needle, significantly reducing the potential for injury among healthcare professionals and other users. In addition to NeedleZap, E Med Future has developed a dental parking station, providing a temporary resting place for hypodermic syringes, and a butterfly needle burner designed for needles not secured to a syringe, particularly useful in IV and kidney dialysis applications. The company’s offerings cater to a diverse clientele, including healthcare professionals, law enforcement and correctional personnel, veterinarians, military personnel, clinical researchers, as well as workers in hospitality and sanitation sectors. This broad market reach underscores E Med Future's commitment to improving safety standards across various industries. Over the years, the company has evolved from its initial focus to become a specialized provider of safety devices, positioning itself as a critical player in the medical devices industry, particularly in the niche of needlestick injury prevention.
What Products and Services Does EMDF Offer?
- Manufacture safety devices aimed at reducing needlestick injuries.
- Develop innovative products like NeedleZap that disintegrate hypodermic needles.
- Create a dental parking station for temporary syringe placement.
- Produce a butterfly needle burner for IV and kidney dialysis applications.
- Serve a diverse clientele including healthcare, law enforcement, and military sectors.
- Focus on enhancing safety standards in various professional environments.
How Does EMDF Make Money?
- Generate revenue through the sale of safety devices and medical equipment.
- Target multiple customer segments including healthcare professionals and law enforcement.
- Leverage product innovation to differentiate offerings in the medical devices market.
What Industry Does EMDF Operate In?
The medical devices industry is experiencing robust growth, driven by increasing healthcare expenditures and a heightened focus on patient safety. Within this landscape, E Med Future, Inc. occupies a niche segment focused on needlestick injury prevention, an area of growing concern as healthcare providers seek to minimize risks associated with needle use. The competitive landscape includes larger firms with extensive resources, yet E Med Future's specialized focus on safety devices positions it uniquely to capitalize on emerging safety regulations and heightened awareness among healthcare professionals.
Who Are EMDF's Key Customers?
- Healthcare professionals seeking to minimize needlestick injuries.
- Law enforcement and correctional personnel requiring safe medical practices.
- Veterinarians needing specialized safety devices for animal care.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 53 |
| 2026-08-26 | 53 |
| 2026-08-29 | 53 |
| 2026-09-01 | 53 |
| 2026-09-04 | 53 |
| 2026-09-07 | 53 |
| 2026-09-10 | 53 |
What changed?
The score has stayed at 53.
Over the same 18 days the stock moved -13.2%.
Company Profile
E Med Future, Inc. operates in the Entertainment industry within the Communication Services sector. It is headquartered in Sarasota, US. The company is led by CEO Gary Kompothecras. EMDF has traded publicly since 2003.
Key Financial Metrics
Return on equity for E Med Future, Inc. stands at -9.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.6%, showing how much profit it generates from its asset base. A current ratio of 1.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -132.2%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
E Med Future, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.06 places it in the distress zone, a signal of elevated financial risk.
EMDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Innovative product offerings focused on safety.
- Strong gross margin indicating potential profitability.
- Niche market focus reduces direct competition.
- Upcoming: Potential partnerships with healthcare institutions to enhance product adoption.
Bear Case
- Small employee base limits operational capacity.
- Negative profit margin reflects current financial challenges.
- Limited brand recognition compared to larger competitors.
- Potential: Increased competition from larger medical device manufacturers.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
EMDF Latest News
No recent news available for EMDF.
EMDF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EMDF.
Price Targets
Wall Street price target analysis for EMDF.
EMDF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EMDF; grades run from A+ (80-100) to F (below 30).
Leadership: Gary G. Kompothecras
CEO
Gary G. Kompothecras has been leading E Med Future, Inc. since its inception in 1990. With a background in healthcare and business management, he has guided the company through various phases of development. His leadership has focused on innovation in safety devices and expanding the company's market reach.
Track Record: Under Gary's leadership, E Med Future has developed key products that address critical safety issues in healthcare. His strategic decisions have positioned the company as a niche provider in the medical devices market, despite its small operational size.
EMDF OTC Market Information
The OTC Other tier is a classification for companies that do not meet the requirements for higher tiers such as OTCQX or OTCQB. This tier typically includes smaller or less established companies, which may have limited financial disclosure and lower trading volumes compared to those on major exchanges.
- OTC Tier: OTC Other
- Limited financial disclosure could impact investment decisions.
- Lower liquidity may lead to difficulties in executing trades.
- Potential for higher volatility compared to stocks on major exchanges.
- Verify the company's financial health and operational metrics.
- Assess the competitive landscape and market positioning.
- Review product certifications and regulatory compliance.
- Investigate management's track record and strategic vision.
- Examine customer feedback and product performance.
- Established history since 1990 indicates longevity in the market.
- Focus on safety devices aligns with increasing healthcare regulations.
- Innovative product development reflects commitment to addressing industry needs.
Common Questions About EMDF (Healthcare)
Is EMDF a good stock?
Stock Expert AI does not rate EMDF buy, sell or hold. E Med Future, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for EMDF?
E Med Future, Inc. faces several risks including intense competition from larger medical device manufacturers that may overshadow its niche offerings.
What are the key factors to evaluate for EMDF?
Evaluate EMDF on fundamentals, analyst consensus, and risk factors. The need for strategic partnerships and potential funding will be crucial for sustaining growth and addressing market needs. Not financial advice.
How frequently does EMDF data refresh on this page?
EMDF's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven EMDF's recent stock price performance?
E Med Future, Inc. (EMDF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative product offerings focused on safety. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EMDF overvalued or undervalued right now?
E Med Future, Inc. (EMDF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of EMDF?
Yes, most major brokerages offer fractional shares of E Med Future, Inc. (EMDF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EMDF's earnings and financial reports?
E Med Future, Inc. (EMDF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for EMDF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial metrics are based on available data, which may not fully represent the company's financial health.